title: Immediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation - the Meo:DrugStar-1 study.
abstract: The study was conducted to evaluate the clinical and angiographic results of the implantation of the paclitaxel-eluting stent Meo:DrugStar ST in patients with symptomatic coronary artery disease. The Meo:DrugStar ST stent has a stainless steel stent platform with a homogenous non-biodegradable coating of paclitaxel mixed with a polyether-based biostable, monophase, and hemocompatible coating. Sixty patients with native coronary artery disease were included in the study. The Meo:DrugStar ST stents were implanted in 60 de novo lesions detected in these patients. Immediate and long-term clinical and angiographic follow-up results were evaluated. There was a high proportion of patients with hypertension (55%) according to JNC-VII. Mean stenosis ratio was 78 +/- 13 %, mean implanted stent diameter was 3.0 +/- 0.4 mm and mean length was 22 +/- 5 mm. Restenosis was detected in 4 (10%) of those patients and 11 (27.5%) of 40 patients had insignificant amount of restenosis. The results of this study indicate a potential benefit of the Meo:DrugStar ST stent for the prevention of stent thrombosis and restenosis in these relatively high-risk patients.
authors.affiliation: Abant Izzet Baysal University, Izzet Baysal Medical Faculty, Cardiology Department Bolu, Turkey. cihangirayten@superonline.com
authors.forename: Cihangir
authors.initials: C
authors.lastname: Uyan
authors.forename: Huseyin
authors.initials: H
authors.lastname: Arinc
authors.forename: Huseyin
authors.initials: H
authors.lastname: Gunduz
authors.forename: Ramazan
authors.initials: R
authors.lastname: Akdemir
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D016009:Chi-Square Distribution; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging / Q000628:therapy*; D023903:Coronary Restenosis / Q000517:prevention & control; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage*; D011474:Prosthesis Design; D013193:Stainless Steel; D016896:Treatment Outcome
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D013193:Stainless Steel; D017239:Paclitaxel